Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Verma

Showing results (421-430 of 459) with videos related to

Pageof 46
Sort By:
Blood Advances|January 9, 2025
Advancing drug development in myelodysplastic syndromesAlain Mina, Kathy L McGraw, Lea Cunningham, et al.
The Journal of Clinical Investigation|February 1, 2019
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinomaNiraj Shenoy, Tushar D Bhagat, John Cheville, et al.
The Journal of Clinical Investigation|May 27, 2025
Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromesSrinivas Aluri, Te Ling, Ellen Fraint, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Initial Whole-Genome Sequencing of Plasma Cell Neoplasms in First Responders and Recovery Workers Exposed to the World Trade Center Attack of September 11, 2001Francesco Maura, Benjamin Diamond, Kylee H Maclachlan, et al.
Blood|September 24, 2024
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohortMendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, et al.
The Journal of Clinical Investigation|February 20, 2024
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependencySarah Aminov, Orsi Giricz, David T Melnekoff, et al.
Blood|May 14, 2008
Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDSLi Zhou, Aaron N Nguyen, Davendra Sohal, et al.
Cancer Discovery|April 5, 2019
Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in HematopoiesisJong Jin Jeong, Xiaorong Gu, Ji Nie, et al.
Plos Computational Biology|April 23, 2020
Vector bionomics and vectorial capacity as emergent properties of mosquito behaviors and ecologySean L Wu, Héctor M Sánchez C, John M Henry, et al.
Haematologica|April 2, 2026
Treatment of <i>TP53</i>-mutated myelodysplastic syndrome and acute myeloid leukemia with lowintensity metronomic decitabine and venetoclaxMendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, et al.
Pageof 46

Showing results (421-430 of 459) with videos related to

Sort By:
Pageof 46
Blood Advances|January 9, 2025
Advancing drug development in myelodysplastic syndromesAlain Mina, Kathy L McGraw, Lea Cunningham, et al.
The Journal of Clinical Investigation|February 1, 2019
Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinomaNiraj Shenoy, Tushar D Bhagat, John Cheville, et al.
The Journal of Clinical Investigation|May 27, 2025
Splicing of erythroid transcription factor is associated with therapeutic response in myelodysplastic syndromesSrinivas Aluri, Te Ling, Ellen Fraint, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2021
Initial Whole-Genome Sequencing of Plasma Cell Neoplasms in First Responders and Recovery Workers Exposed to the World Trade Center Attack of September 11, 2001Francesco Maura, Benjamin Diamond, Kylee H Maclachlan, et al.
Blood|September 24, 2024
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohortMendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, et al.
The Journal of Clinical Investigation|February 20, 2024
Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependencySarah Aminov, Orsi Giricz, David T Melnekoff, et al.
Blood|May 14, 2008
Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDSLi Zhou, Aaron N Nguyen, Davendra Sohal, et al.
Cancer Discovery|April 5, 2019
Cytokine-Regulated Phosphorylation and Activation of TET2 by JAK2 in HematopoiesisJong Jin Jeong, Xiaorong Gu, Ji Nie, et al.
Plos Computational Biology|April 23, 2020
Vector bionomics and vectorial capacity as emergent properties of mosquito behaviors and ecologySean L Wu, Héctor M Sánchez C, John M Henry, et al.
Haematologica|April 2, 2026
Treatment of <i>TP53</i>-mutated myelodysplastic syndrome and acute myeloid leukemia with lowintensity metronomic decitabine and venetoclaxMendel Goldfinger, Ioannis Mantzaris, Aditi Shastri, et al.
Pageof 46